1. Home
  2. Companies
  3. AstraZeneca
AS

AstraZeneca

About

In 1999, two science-based companies with shared visions came together to form AstraZeneca: Sweden's Astra AB and the UK's Zeneca Group PLC. This strategic merger combined decades of pharmaceutical expertise, creating a global powerhouse uniquely positioned to push the boundaries of scientific discovery. What began as a union of strengths has evolved into a relentless pursuit of breakthrough therapies, with the company investing billions annually in research and development to transform patient outcomes across oncology, biopharmaceuticals, respiratory, and rare diseases.

Today, AstraZeneca stands at the forefront of precision medicine and next-generation therapeutics, harnessing the power of data science, AI, and innovative technologies like cell therapies. With 197 projects in the pipeline and 16 blockbuster medicines, the company operates from six strategic R&D centres spanning Cambridge, Gothenburg, Gaithersburg, Boston, Shanghai, and Beijing. Their bold aspiration to deliver 20 new medicines by 2030 reflects an unwavering commitment to following the science and putting patients first - values that have driven every decision since that pivotal merger more than two decades ago.

Similar companies

VI

Vistra

At Vistra, we believe that building the leading integrated energy company requires more than just generation capacity - it demands an unwavering commitment to how we work together. Our analysis-driven, disciplined culture means every team member approaches decisions with data and integrity. Collaboration and information sharing aren't just encouraged; they are fundamental to how we conduct our day-to-day activities across all functions. We pride ourselves on an unmatched work ethic that drives us to compete to win, but never at the expense of doing business the right way. Our purpose of 'lighting up lives, powering a better way forward' attracts people who care deeply about their stakeholders - customers, communities where we live and work, fellow employees, and investors. We maintain productive, respectful relationships with elected officials, regulators, and community leaders while striving for the full value of our enterprise. Whether you're in our generation facilities managing power plants, on our retail teams serving 5 million customers, or in our corporate offices driving strategic initiatives, you'll find a culture that values transparency, cross-functional teamwork, and real ownership of outcomes. This is what enables us to provide essential power resources across the nation while transforming toward a sustainable energy future.

TE

Teneo

Teneo is the global CEO advisory firm, partnering with clients worldwide to navigate complex business challenges and achieve strategic objectives. The firm provides comprehensive advisory services across five business segments: Financial Advisory, Management Consulting, Strategy & Communications, Risk Advisory, and People Advisory. Teneo serves a significant number of Fortune 100 and FTSE 100 companies, delivering integrated solutions in strategic communications, investor relations, financial restructuring, management consulting, cyber risk, organizational design, executive search, geopolitics, and corporate governance. With more than 1,800 professionals operating across 45+ offices globally, Teneo leverages its expansive network of senior advisors and deep industry expertise to help clients solve their most critical business issues. The firm's leadership includes Chairwoman Ursula Burns and CEO Paul Keary, guiding a diverse team of experts who operate as an extension of client organizations to understand broader landscapes and introduce innovative thinking. Teneo's commitment to excellence and global reach positions it as a trusted advisor to the world's leading corporations and financial institutions.

ST

Stellenangebote

Drees & Sommer exists to create a future worth living by transforming how the built environment is designed, constructed, and operated. The construction and real estate industries account for nearly 40% of global carbon emissions, yet traditional approaches remain fragmented, inefficient, and unsustainable. Drees & Sommer tackles this challenge head-on by providing integrated consulting and implementation services that unite vision with reality - delivering projects that are economically viable, ecologically responsible, and digitally enabled. Since 1970, the company has grown from a small Stuttgart engineering office into a global partner-managed consultancy with 6,500 professionals across 70+ cities. Their interdisciplinary teams work on 6,872+ projects worldwide, uniting apparent opposites: tradition and innovation, economy and ecology, analog and digital, efficiency and well-being. As a sustainability pioneer and digitalization driver, Drees & Sommer doesn't just advise clients - they implement solutions that measurably reduce environmental impact while creating lasting value. From carbon-neutral buildings to resilient infrastructure and future-proof industrial facilities, they're proving that sustainable development isn't just necessary - it's the foundation of competitive advantage in a changing world.

AD

AdvanSix

AdvanSix plays a critical role in global supply chains, innovating and delivering essential products that touch millions of lives every day. As a diversified chemistry company, AdvanSix produces vital materials including nylon solutions, chemical intermediates, and plant nutrients that serve customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, and electronics. The company's vertically integrated value chain of U.S.-based manufacturing facilities enables reliable and sustainable supply while maintaining operational excellence. Guided by core values of Safety, Integrity, Accountability, and Respect, AdvanSix combines nearly 140 years of chemistry expertise with modern innovation to create solutions that make the planet safer, healthier, more sustainable, and beautiful. From the nylon in food packaging that extends shelf life to ammonium sulfate fertilizers that nourish crops worldwide, AdvanSix's chemistries turn possibilities into real-world solutions. The company became an independent publicly traded entity in 2016 following its spin-off from Honeywell, building on a legacy of chemical manufacturing excellence.

TP

Tetra Pak

Tetra Pak is the world's leading food processing and packaging solutions company, working closely with customers and suppliers to provide safe food for millions of people globally. Founded in Sweden in 1951, the company pioneered the revolutionary tetrahedron packaging system that transformed how food and beverages are distributed and consumed. Today, Tetra Pak operates in more than 160 countries, employing over 24,000 people who share a mission to make food safe and available everywhere. The company's comprehensive solutions span the entire food production chain - from processing and packaging to distribution services - serving customers in dairy, cheese, juice, plant-based products, ice cream, and many other food categories. Tetra Pak's innovative carton packages are designed for consumer convenience, food safety, optimal shelf life, and environmental sustainability. The company continues to drive innovation in sustainable materials, waste reduction, and recycling while maintaining its commitment to protect food, people, and the planet through responsible business practices and cutting-edge technology.

IP

Ipsen

Ipsen is a global, mid-sized biopharmaceutical company focused on improving patients' lives through research and innovation. With over 5,000 dedicated professionals worldwide, the company operates in 88 countries, bringing transformative medicines to patients across five continents. Ipsen's expertise spans three core therapeutic areas: Oncology, Rare Disease, and Neuroscience, where the team tackles areas of high unmet medical need through cutting-edge research and development. Founded in 1929 by Dr. Henri Beaufour, Ipsen has built nearly a century of experience in specialty care medicines. The company combines the resources to make real impact with the agility to move fast, aiming to deliver at least one new molecular entity or meaningful indication every year. With global hubs in the U.S., France, and the U.K., Ipsen maintains an entrepreneurial mindset while scaling its operations to serve patients worldwide.